{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:14:00Z","timestamp":1783494840846,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Chinese Medicine Guangdong Laboratory 2024 Graduate Program","award":["HQL2024GR004"],"award-info":[{"award-number":["HQL2024GR004"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82230126"],"award-info":[{"award-number":["82230126"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82505225"],"award-info":[{"award-number":["82505225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82574742"],"award-info":[{"award-number":["82574742"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Key Research and Development Program of China","award":["2022YFC3500100"],"award-info":[{"award-number":["2022YFC3500100"]}]},{"name":"the Noncommunicable Chronic Diseases\u2014National Science and Technology Major Project","award":["2023ZD0502600"],"award-info":[{"award-number":["2023ZD0502600"]}]},{"name":"Guangdong Provincial Key Laboratory of Syndrome and Formula","award":["2022B1212010012"],"award-info":[{"award-number":["2022B1212010012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ventricular remodeling is a key pathological feature of chronic heart failure (CHF). Following myocardial infarction (MI), impaired macrophage efferocytosis sustains cardiac inflammation, disrupts tissue repair, and accelerates adverse remodeling and dysfunction. Qishen Granules (QSG) is a classical traditional Chinese medicine formulation used in the clinical treatment of heart failure. However, its regulatory effects on efferocytosis in resident cardiac macrophages (RCMs) remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to elucidate the molecular mechanisms by which QSG regulates Legumain-mediated efferocytosis in RCMs and to identify the key bioactive compounds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A mouse model of post-MI heart failure was established via ligation of the left anterior descending coronary artery. The therapeutic effects of QSG were evaluated in isolated RCMs obtained using magnetic-activated cell sorting. Mechanistic investigations were conducted using transcriptomic analysis, network pharmacology, live-cell imaging, and siRNA-mediated gene silencing. In addition, UPLC-Q-Exactive MS, molecular docking, and molecular dynamics simulations were employed to systematically study the active compounds of QSG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>QSG treatment restored the population of RCMs and enhanced their efferocytic capacity in CHF, thereby reducing cardiomyocyte apoptosis, promoting inflammatory resolution, and improving ventricular structure and function. Mechanistically, QSG upregulated Legumain expression and activated the Arg1\/Rac1 signaling axis to facilitate cytoskeletal remodeling and enhance phagocytic efficiency. Further analyses identified tanshinone IIA, neocryptotanshinone and calycosin as the core bioactive compounds of QSG. All three compounds upregulated Legumain expression and exhibited stable binding affinity toward Legumain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>QSG restores efferocytic capacity in RCMs by targeting the Legumain\/Arg1\/Rac1 signaling axis, thereby attenuating adverse ventricular remodeling in CHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01461-6","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:25:55Z","timestamp":1783491955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Qishen Granules attenuate adverse ventricular remodeling in chronic heart failure by promoting Legumain\/Arg1\/Rac1-mediated efferocytosis of resident cardiac macrophages"],"prefix":"10.1186","volume":"21","author":[{"given":"Meijiao","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixuan","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huishi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"1461_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","volume":"21","author":"MS Khan","year":"2024","unstructured":"Khan MS, Shahid I, Bennis A, Rakisheva A, Metra M, Butler J. Global epidemiology of heart failure. Nat Rev Cardiol. 2024;21:717\u201334. https:\/\/doi.org\/10.1038\/s41569-024-01046-6.","journal-title":"Nat Rev Cardiol"},{"key":"1461_CR2","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.jacc.2025.03.544","volume":"85","author":"M Riccardi","year":"2025","unstructured":"Riccardi M, Pabon MA, Bhatt AS, Savarese G, Metra M, Volterrani M, et al. Heart failure with improved ejection fraction. J Am Coll Cardiol. 2025;85:2401\u201315. https:\/\/doi.org\/10.1016\/j.jacc.2025.03.544.","journal-title":"J Am Coll Cardiol"},{"key":"1461_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41569-022-00823-5","volume":"20","author":"J Yap","year":"2023","unstructured":"Yap J, Irei J, Lozano-Gerona J, Vanapruks S, Bishop T, Boisvert WA. Macrophages in cardiac remodelling after myocardial infarction. Nat Rev Cardiol. 2023;20:373\u201385. https:\/\/doi.org\/10.1038\/s41569-022-00823-5.","journal-title":"Nat Rev Cardiol"},{"key":"1461_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"A Yurdagul","year":"2020","unstructured":"Yurdagul A, Subramanian M, Wang X, Crown SB, Ilkayeva OR, Darville L, et al. Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab. 2020;31:518-533.e10. https:\/\/doi.org\/10.1016\/j.cmet.2020.01.001.","journal-title":"Cell Metab"},{"key":"1461_CR5","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","volume":"24","author":"G Bajpai","year":"2018","unstructured":"Bajpai G, Schneider C, Wong N, Bredemeyer A, Hulsmans M, Nahrendorf M, et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med. 2018;24:1234\u201345. https:\/\/doi.org\/10.1038\/s41591-018-0059-x.","journal-title":"Nat Med"},{"key":"1461_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s42255-022-00715-5","volume":"5","author":"K Zhang","year":"2023","unstructured":"Zhang K, Wang Y, Chen S, Mao J, Jin Y, Ye H, et al. TREM2hi resident macrophages protect the septic heart by maintaining cardiomyocyte homeostasis. Nat Metab. 2023;5:129\u201346. https:\/\/doi.org\/10.1038\/s42255-022-00715-5.","journal-title":"Nat Metab"},{"key":"1461_CR7","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.121.057549","volume":"145","author":"D Jia","year":"2022","unstructured":"Jia D, Chen S, Bai P, Luo C, Liu J, Sun A, et al. Cardiac resident macrophage-derived legumain improves cardiac repair by promoting clearance and degradation of apoptotic cardiomyocytes after myocardial infarction. Circulation. 2022;145:1542\u201356. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057549.","journal-title":"Circulation"},{"key":"1461_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/698531","author":"Y Wang","year":"2012","unstructured":"Wang Y, Liu Z, Li C, Li D, Ouyang Y, Yu J, et al. Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease. Evid Based Complement Alternat Med. 2012. https:\/\/doi.org\/10.1155\/2012\/698531.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1461_CR9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fphar.2019.01399","volume":"10","author":"W Lu","year":"2019","unstructured":"Lu W, Wang Q, Sun X, He H, Wang Q, Wu Y, et al. Qishen Granule improved cardiac remodeling via balancing M1 and M2 macrophages. Front Pharmacol. 2019;10:1399. https:\/\/doi.org\/10.3389\/fphar.2019.01399.","journal-title":"Front Pharmacol"},{"key":"1461_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.eng.2025.09.010","volume":"55","author":"X Mou","year":"2025","unstructured":"Mou X, Li L, Liu X, Zhang A, He T, Rao B, et al. Single-nucleus RNA sequencing reveals the mechanism of neonatal hypoxic\u2013ischemic encephalopathy and the neuroprotection effects of salvianolic acid C. Engineering. 2025;55:269\u201390. https:\/\/doi.org\/10.1016\/j.eng.2025.09.010.","journal-title":"Engineering"},{"key":"1461_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154625","volume":"110","author":"Y Yang","year":"2023","unstructured":"Yang Y, Shao M, Yao J, Yang S, Cheng W, Ma L, et al. Neocryptotanshinone protects against myocardial ischemia-reperfusion injury by promoting autolysosome degradation of protein aggregates via the ERK1\/2-Nrf2-LAMP2 pathway. Phytomedicine. 2023;110:154625. https:\/\/doi.org\/10.1016\/j.phymed.2022.154625.","journal-title":"Phytomedicine"},{"key":"1461_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108599","volume":"112","author":"X Zhang","year":"2019","unstructured":"Zhang X, Wang Q, Wang X, Chen X, Shao M, Zhang Q, et al. Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs\/mTOR-dependent autophagy pathway. Biomed Pharmacother. 2019;112:108599. https:\/\/doi.org\/10.1016\/j.biopha.2019.108599.","journal-title":"Biomed Pharmacother"},{"key":"1461_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154277","volume":"104","author":"G Chen","year":"2022","unstructured":"Chen G, Xu H, Xu T, Ding W, Zhang G, Hua Y, et al. Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways. Phytomedicine. 2022;104:154277. https:\/\/doi.org\/10.1016\/j.phymed.2022.154277.","journal-title":"Phytomedicine"},{"key":"1461_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.152949","volume":"62","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, Wang Q, Yang X, Ren Y, Jiao S, Zhu Q, et al. Qishen granule attenuates cardiac fibrosis by regulating TGF-\u03b2 \/Smad3 and GSK-3\u03b2 pathway. Phytomedicine. 2019;62:152949. https:\/\/doi.org\/10.1016\/j.phymed.2019.152949.","journal-title":"Phytomedicine"},{"key":"1461_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156467","volume":"140","author":"X Zhang","year":"2025","unstructured":"Zhang X, Chang X, Chai R, Zhang X, Li J, Guo Z, et al. Xin-Fu-Kang oral liquid mitigates chronic heart failure through NR4A1-dependent regulation of endoplasmic reticulum-mitochondrial crosstalk in cardiomyocytes. Phytomedicine. 2025;140:156467. https:\/\/doi.org\/10.1016\/j.phymed.2025.156467.","journal-title":"Phytomedicine"},{"key":"1461_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11655-024-3667-y","volume":"31","author":"X-Q Sun","year":"2025","unstructured":"Sun X-Q, Li X, Li Y-Q, Lu X-Y, Liu X-N, Cui L-W, et al. Qishen granules modulate metabolism flexibility against myocardial infarction via HIF-1 \u03b1-dependent mechanisms in rats. Chin J Integr Med. 2025;31:215\u201327. https:\/\/doi.org\/10.1007\/s11655-024-3667-y.","journal-title":"Chin J Integr Med"},{"key":"1461_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154265","volume":"104","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang J, Hong M, Huang J, Xu S, Wang R, et al. Suo quan wan ameliorates bladder overactivity and regulates neurotransmission via regulating myosin va protein expression. Phytomedicine. 2022;104:154265. https:\/\/doi.org\/10.1016\/j.phymed.2022.154265.","journal-title":"Phytomedicine"},{"key":"1461_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155879","volume":"132","author":"J Lv","year":"2024","unstructured":"Lv J, Shi S, Fu Z, Wang Y, Duan C, Hu S, et al. Exploring the inflammation-related mechanisms of Lingguizhugan decoction on right ventricular remodeling secondary to pulmonary arterial hypertension based on integrated strategy using UPLC-HRMS, systems biology approach, and experimental validation. Phytomedicine. 2024;132:155879. https:\/\/doi.org\/10.1016\/j.phymed.2024.155879.","journal-title":"Phytomedicine"},{"key":"1461_CR19","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1021\/acs.jcim.0c00613","volume":"60","author":"T-S Lee","year":"2020","unstructured":"Lee T-S, Allen BK, Giese TJ, Guo Z, Li P, Lin C, et al. Alchemical binding free energy calculations in AMBER20: advances and best practices for drug discovery. J Chem Inf Model. 2020;60:5595\u2013623. https:\/\/doi.org\/10.1021\/acs.jcim.0c00613.","journal-title":"J Chem Inf Model"},{"key":"1461_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","volume":"51","author":"T Hou","year":"2011","unstructured":"Hou T, Wang J, Li Y, Wang W. Assessing the performance of the MM\/PBSA and MM\/GBSA methods: I. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model. 2011;51:69\u201382. https:\/\/doi.org\/10.1021\/ci100275a.","journal-title":"J Chem Inf Model"},{"key":"1461_CR21","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/jssc.201900980","volume":"43","author":"Y Li","year":"2020","unstructured":"Li Y, Liu J, Su R, Li Q, Chen Y, Yang J, et al. Pseudotargeted screening and determination of constituents in Qishen granule based on compound biosynthetic correlation using UHPLC coupled with high-resolution MS. J Sep Sci. 2020;43:1032\u201342. https:\/\/doi.org\/10.1002\/jssc.201900980.","journal-title":"J Sep Sci"},{"key":"1461_CR22","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3390\/molecules22111853","volume":"22","author":"N Zhang","year":"2017","unstructured":"Zhang N, Li Y, Sun J, Li C, Song Y, Li J, et al. Simultaneous determination of twenty-five compounds in rat plasma using ultra-high performance liquid chromatography-polarity switching tandem mass spectrometry and its application to a pharmacokinetic study. Mol Basel Switz. 2017;22:1853. https:\/\/doi.org\/10.3390\/molecules22111853.","journal-title":"Mol Basel Switz"},{"key":"1461_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-021-00722-w","volume":"28","author":"C Piamsiri","year":"2021","unstructured":"Piamsiri C, Maneechote C, Siri-Angkul N, Chattipakorn SC, Chattipakorn N. Targeting necroptosis as therapeutic potential in chronic myocardial infarction. J Biomed Sci. 2021;28:25. https:\/\/doi.org\/10.1186\/s12929-021-00722-w.","journal-title":"J Biomed Sci"},{"key":"1461_CR24","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","volume":"43","author":"S Frantz","year":"2022","unstructured":"Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J. 2022;43:2549\u201361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac223.","journal-title":"Eur Heart J"},{"key":"1461_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jacasi.2024.01.013","volume":"4","author":"J Feng","year":"2024","unstructured":"Feng J, Zhang Y, Zhang J. Epidemiology and burden of heart failure in Asia. JACC Asia. 2024;4:249\u201364. https:\/\/doi.org\/10.1016\/j.jacasi.2024.01.013.","journal-title":"JACC Asia"},{"key":"1461_CR26","doi-asserted-by":"publisher","first-page":"1017734","DOI":"10.3389\/fphar.2022.1017734","volume":"13","author":"K Du","year":"2022","unstructured":"Du K, Liu J, Tan N, Huang X, Wang J, Zhao H, et al. The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial. Front Pharmacol. 2022;13:1017734. https:\/\/doi.org\/10.3389\/fphar.2022.1017734.","journal-title":"Front Pharmacol"},{"key":"1461_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jare.2025.05.006","volume":"80","author":"P Lu","year":"2025","unstructured":"Lu P, Shen R, Yang J, Wu L, Wang R. Dynamic regulation and targeted interventions of macrophages in ischemia\u2013reperfusion injury. J Adv Res. 2025;80:705\u201323. https:\/\/doi.org\/10.1016\/j.jare.2025.05.006.","journal-title":"J Adv Res"},{"key":"1461_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI171953","volume":"133","author":"EB Thorp","year":"2023","unstructured":"Thorp EB. Cardiac macrophages and emerging roles for their metabolism after myocardial infarction. J Clin Invest. 2023;133:e171953. https:\/\/doi.org\/10.1172\/JCI171953.","journal-title":"J Clin Invest"},{"key":"1461_CR29","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","volume":"75","author":"SP Murphy","year":"2020","unstructured":"Murphy SP, Kakkar R, McCarthy CP, Januzzi JL. Inflammation in heart failure: JACC State-of-the-art review. J Am Coll Cardiol. 2020;75:1324\u201340. https:\/\/doi.org\/10.1016\/j.jacc.2020.01.014.","journal-title":"J Am Coll Cardiol"},{"key":"1461_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.eng.2024.05.015","volume":"42","author":"X Chen","year":"2024","unstructured":"Chen X, Du Z, Guo D, Guo J, Sun Q, Liu T, et al. Activation of the macrophage-associated inflammasome exacerbates myocardial fibrosis through the 15-HETE-mediated pathway in acute myocardial infarction. Engineering. 2024;42:143\u201356. https:\/\/doi.org\/10.1016\/j.eng.2024.05.015.","journal-title":"Engineering"},{"key":"1461_CR31","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.cell.2017.03.050","volume":"169","author":"M Hulsmans","year":"2017","unstructured":"Hulsmans M, Clauss S, Xiao L, Aguirre AD, King KR, Hanley A, et al. Macrophages facilitate electrical conduction in the heart. Cell. 2017;169:510-522.e20. https:\/\/doi.org\/10.1016\/j.cell.2017.03.050.","journal-title":"Cell"},{"key":"1461_CR32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41569-024-01109-8","volume":"22","author":"S Yang","year":"2025","unstructured":"Yang S, Penna V, Lavine KJ. Functional diversity of cardiac macrophages in health and disease. Nat Rev Cardiol. 2025;22:431\u201342. https:\/\/doi.org\/10.1038\/s41569-024-01109-8.","journal-title":"Nat Rev Cardiol"},{"key":"1461_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41590-018-0272-2","volume":"20","author":"SA Dick","year":"2019","unstructured":"Dick SA, Macklin JA, Nejat S, Momen A, Clemente-Casares X, Althagafi MG, et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat Immunol. 2019;20:29\u201339. https:\/\/doi.org\/10.1038\/s41590-018-0272-2.","journal-title":"Nat Immunol"},{"key":"1461_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101932","volume":"6","author":"C Ding","year":"2025","unstructured":"Ding C, Tang G, Sun Y, Fu X, Tian Y, Zhan J, et al. A functional cardiac patch promotes cardiac repair by modulating the CCR2- cardiac-resident macrophage niche and their cell crosstalk. Cell Rep Med. 2025;6:101932. https:\/\/doi.org\/10.1016\/j.xcrm.2025.101932.","journal-title":"Cell Rep Med"},{"key":"1461_CR35","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2024.11.018","volume":"58","author":"C Lantz","year":"2025","unstructured":"Lantz C, Becker A, DeBerge M, Filipp M, Glinton K, Ananthakrishnan A, et al. Early-age efferocytosis directs macrophage arachidonic acid metabolism for tissue regeneration. Immunity. 2025;58:344-361.e7. https:\/\/doi.org\/10.1016\/j.immuni.2024.11.018.","journal-title":"Immunity"},{"key":"1461_CR36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016360","volume":"9","author":"I Gregersen","year":"2020","unstructured":"Gregersen I, Michelsen AE, Lunde NN, \u00c5kerblom A, Lakic TG, Skjelland M, et al. Legumain in acute coronary syndromes: a substudy of the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Heart Assoc. 2020;9:e016360. https:\/\/doi.org\/10.1161\/JAHA.120.016360.","journal-title":"J Am Heart Assoc"},{"key":"1461_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415983","volume":"23","author":"R Solberg","year":"2022","unstructured":"Solberg R, Lunde NN, Forbord KM, Okla M, Kassem M, Jafari A. The mammalian cysteine protease legumain in health and disease. Int J Mol Sci. 2022;23:15983. https:\/\/doi.org\/10.3390\/ijms232415983.","journal-title":"Int J Mol Sci"},{"key":"1461_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202417831","volume":"37","author":"Z Liu","year":"2025","unstructured":"Liu Z, Chen C, Zhang Y, Ji F, Liu H, Du H, et al. Legumain in situ engineering promotes efferocytosis of CAR macrophage to treat cardiac fibrosis. Adv Mater. 2025;37:e2417831. https:\/\/doi.org\/10.1002\/adma.202417831.","journal-title":"Adv Mater"},{"key":"1461_CR39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720065115","author":"X Liao","year":"2018","unstructured":"Liao X, Shen Y, Zhang R, Sugi K, Vasudevan NT, Alaiti MA, et al. Distinct roles of resident and nonresident macrophages in nonischemic cardiomyopathy. Proc Natl Acad Sci. 2018. https:\/\/doi.org\/10.1073\/pnas.1720065115.","journal-title":"Proc Natl Acad Sci"},{"key":"1461_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.joim.2022.01.006","volume":"20","author":"J-Y Zhao","year":"2022","unstructured":"Zhao J-Y, Pu J, Fan J, Feng X-Y, Xu J-W, Zhang R, et al. Tanshinone IIA prevents acute lung injury by regulating macrophage polarization. J Integr Med. 2022;20:274\u201380. https:\/\/doi.org\/10.1016\/j.joim.2022.01.006.","journal-title":"J Integr Med"},{"key":"1461_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.641848","volume":"12","author":"Z Song","year":"2021","unstructured":"Song Z, Feng J, Zhang Q, Deng S, Yu D, Zhang Y, et al. Tanshinone IIA protects against cerebral ischemia reperfusion injury by regulating microglial activation and polarization via NF-\u03baB pathway. Front Pharmacol. 2021;12:641848. https:\/\/doi.org\/10.3389\/fphar.2021.641848.","journal-title":"Front Pharmacol"},{"key":"1461_CR42","doi-asserted-by":"publisher","first-page":"1497733","DOI":"10.3389\/fphar.2024.1497733","volume":"15","author":"Q Han","year":"2024","unstructured":"Han Q, Shi J, Yu Y, Yuan H, Guo Y, Liu X, et al. Calycosin alleviates ferroptosis and attenuates doxorubicin-induced myocardial injury via the Nrf2\/SLC7A11\/GPX4 signaling pathway. Front Pharmacol. 2024;15:1497733. https:\/\/doi.org\/10.3389\/fphar.2024.1497733.","journal-title":"Front Pharmacol"},{"key":"1461_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114868","volume":"163","author":"L Ma","year":"2023","unstructured":"Ma L, Shao M, Cheng W, Jiang J, Chen X, Tan N, et al. Neocryptotanshinone ameliorates insufficient energy production in heart failure by targeting retinoid X receptor alpha. Biomed Pharmacother. 2023;163:114868. https:\/\/doi.org\/10.1016\/j.biopha.2023.114868.","journal-title":"Biomed Pharmacother"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01461-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01461-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01461-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:25:56Z","timestamp":1783491956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01461-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1461"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01461-6","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiment was approved by the Experimental Animal Ethics Committee of School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine (ZYD-2025-082).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}